| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.85e-09 | 26 | 93 | 6 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.49e-07 | 52 | 93 | 6 | GO:0005272 | |
| GeneOntologyMolecularFunction | sodium ion binding | 4.26e-07 | 14 | 93 | 4 | GO:0031402 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.35e-06 | 171 | 93 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 6.09e-06 | 26 | 93 | 4 | GO:0031420 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity | 2.15e-05 | 2 | 93 | 2 | GO:0033872 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.00e-04 | 343 | 93 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.89e-04 | 459 | 93 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 3.18e-04 | 465 | 93 | 9 | GO:0046873 | |
| GeneOntologyMolecularFunction | creatine kinase activity | 3.18e-04 | 6 | 93 | 2 | GO:0004111 | |
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 3.18e-04 | 6 | 93 | 2 | GO:0008510 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity | 4.44e-04 | 7 | 93 | 2 | GO:0008467 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, nitrogenous group as acceptor | 5.90e-04 | 8 | 93 | 2 | GO:0016775 | |
| GeneOntologyMolecularFunction | channel activity | 7.61e-04 | 525 | 93 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 7.72e-04 | 526 | 93 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | nucleoside triphosphate diphosphatase activity | 9.42e-04 | 10 | 93 | 2 | GO:0047429 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1S SLC4A7 SLC4A8 SCN1A SCN2A SCN3A SCN4A SCN9A CACNA1H CHRNE | 1.04e-03 | 664 | 93 | 10 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1S SLC4A7 SLC4A8 CLCN1 SCN1A SCN2A SCN3A SCN4A SCN9A CACNA1H CHRNE | 1.14e-03 | 793 | 93 | 11 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 1.62e-03 | 13 | 93 | 2 | GO:0140410 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.62e-03 | 182 | 93 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.70e-03 | 184 | 93 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.88e-03 | 14 | 93 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 2.17e-03 | 15 | 93 | 2 | GO:0034483 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 2.59e-03 | 627 | 93 | 9 | GO:0022890 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1S SLC4A7 SLC4A8 CLCN1 SCN1A SCN2A SCN3A SCN4A SCN9A CACNA1H | 2.76e-03 | 758 | 93 | 10 | GO:0015318 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.79e-03 | 17 | 93 | 2 | GO:0099508 | |
| GeneOntologyBiologicalProcess | muscle contraction | CACNA1S ADRA2B CLCN1 SYNM SCN1A SCN2A SCN3A SCN4A SCN9A CACNA1H LTB4R AGRN UTY CHRNE | 2.34e-09 | 400 | 91 | 14 | GO:0006936 |
| GeneOntologyBiologicalProcess | striated muscle contraction | CACNA1S SYNM SCN1A SCN2A SCN3A SCN4A SCN9A CACNA1H AGRN UTY CHRNE | 3.07e-09 | 217 | 91 | 11 | GO:0006941 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.09e-08 | 36 | 91 | 6 | GO:0086010 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 3.43e-08 | 112 | 91 | 8 | GO:0019226 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 9.16e-08 | 127 | 91 | 8 | GO:0070252 | |
| GeneOntologyBiologicalProcess | muscle system process | CACNA1S ADRA2B CLCN1 SYNM SCN1A SCN2A SCN3A SCN4A SCN9A CACNA1H LTB4R AGRN UTY CHRNE | 1.18e-07 | 547 | 91 | 14 | GO:0003012 |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.79e-07 | 93 | 91 | 7 | GO:0086003 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 3.46e-07 | 63 | 91 | 6 | GO:0019228 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 3.48e-07 | 208 | 91 | 9 | GO:0035725 | |
| GeneOntologyBiologicalProcess | sodium ion transport | SPTBN4 SLC4A7 SLC4A8 SCN1A SCN2A SCN3A SCN4A SCN9A CACNA1H AGRN | 3.75e-07 | 275 | 91 | 10 | GO:0006814 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 3.85e-07 | 153 | 91 | 8 | GO:0030048 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 7.50e-07 | 167 | 91 | 8 | GO:0060048 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.08e-06 | 121 | 91 | 7 | GO:0051899 | |
| GeneOntologyBiologicalProcess | heart contraction | 6.76e-06 | 298 | 91 | 9 | GO:0060047 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 7.94e-06 | 62 | 91 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | heart process | 9.04e-06 | 309 | 91 | 9 | GO:0003015 | |
| GeneOntologyBiologicalProcess | circulatory system process | SPTBN4 ADRA2B SLC4A8 AVPR1B SCN1A SCN2A SCN3A SCN4A SCN9A CACNA1H AGRN UTY EMILIN1 | 1.93e-05 | 733 | 91 | 13 | GO:0003013 |
| GeneOntologyBiologicalProcess | blood circulation | SPTBN4 ADRA2B AVPR1B SCN1A SCN2A SCN3A SCN4A SCN9A CACNA1H AGRN UTY EMILIN1 | 2.73e-05 | 648 | 91 | 12 | GO:0008015 |
| GeneOntologyBiologicalProcess | action potential | 3.05e-05 | 201 | 91 | 7 | GO:0001508 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | PANK2 SLC4A8 CLCN1 SCN1A SCN2A SCN3A SCN4A SCN9A CACNA1H AGRN CHRNE | 3.50e-05 | 559 | 91 | 11 | GO:0042391 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 4.16e-05 | 87 | 91 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate biosynthetic process | 1.53e-04 | 61 | 91 | 4 | GO:0033866 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate biosynthetic process | 1.53e-04 | 61 | 91 | 4 | GO:0034030 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate biosynthetic process | 1.53e-04 | 61 | 91 | 4 | GO:0034033 | |
| GeneOntologyBiologicalProcess | phosphocreatine metabolic process | 1.91e-04 | 5 | 91 | 2 | GO:0006603 | |
| GeneOntologyBiologicalProcess | phosphagen biosynthetic process | 1.91e-04 | 5 | 91 | 2 | GO:0042396 | |
| GeneOntologyBiologicalProcess | phosphocreatine biosynthetic process | 1.91e-04 | 5 | 91 | 2 | GO:0046314 | |
| GeneOntologyBiologicalProcess | phosphagen metabolic process | 1.91e-04 | 5 | 91 | 2 | GO:0006599 | |
| GeneOntologyBiologicalProcess | sulfur compound metabolic process | 2.11e-04 | 365 | 91 | 8 | GO:0006790 | |
| GeneOntologyBiologicalProcess | metal ion transport | SPTBN4 CACNA1S SLC4A7 SLC4A8 SCN1A SCN2A SCN3A SCN4A SCN9A CACNA1H HSD3B1 AGRN GP5 | 4.33e-04 | 1000 | 91 | 13 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SPTBN4 CACNA1S SLC4A7 SLC4A8 SCN1A SCN2A SCN3A SCN4A SCN9A CACNA1H HSD3B1 AGRN CHRNE GP5 | 5.26e-04 | 1157 | 91 | 14 | GO:0006812 |
| GeneOntologyBiologicalProcess | clustering of voltage-gated sodium channels | 5.30e-04 | 8 | 91 | 2 | GO:0045162 | |
| GeneOntologyBiologicalProcess | threonine metabolic process | 5.30e-04 | 8 | 91 | 2 | GO:0006566 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 6.41e-11 | 17 | 90 | 6 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 2.36e-09 | 29 | 90 | 6 | GO:0034706 | |
| GeneOntologyCellularComponent | sarcolemma | 1.65e-06 | 190 | 90 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 3.65e-05 | 378 | 90 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | cation channel complex | 7.02e-05 | 235 | 90 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | node of Ranvier | 8.34e-05 | 20 | 90 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | axon initial segment | 2.60e-04 | 29 | 90 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 4.20e-04 | 523 | 90 | 9 | GO:1902495 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1S SGCB SCN1A SCN2A SCN3A SCN4A SCN9A CACNA1H EMILIN1 CHRNE GP5 | 5.45e-04 | 785 | 90 | 11 | GO:0098797 |
| GeneOntologyCellularComponent | main axon | 5.93e-04 | 89 | 90 | 4 | GO:0044304 | |
| GeneOntologyCellularComponent | transporter complex | 6.03e-04 | 550 | 90 | 9 | GO:1990351 | |
| GeneOntologyCellularComponent | vacuolar lumen | 1.04e-03 | 178 | 90 | 5 | GO:0005775 | |
| HumanPheno | Cyanosis | 1.11e-05 | 117 | 35 | 7 | HP:0000961 | |
| HumanPheno | Photosensitive myoclonic seizure | 1.63e-05 | 8 | 35 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 1.63e-05 | 8 | 35 | 3 | HP:0200048 | |
| HumanPheno | Feeding difficulties in infancy | POMT2 SPTBN4 UBA1 GALC PANK2 CLCN1 SCN1A SCN3A SCN4A SCN9A EMG1 ELP1 AGRN CHRNE | 1.65e-05 | 594 | 35 | 14 | HP:0008872 |
| HumanPheno | Muscle stiffness | 1.73e-05 | 83 | 35 | 6 | HP:0003552 | |
| HumanPheno | Abnormal facial expression | 2.64e-05 | 185 | 35 | 8 | HP:0005346 | |
| HumanPheno | Abnormality of masticatory muscle | 2.93e-05 | 27 | 35 | 4 | HP:0410011 | |
| HumanPheno | Abnormal nervous system electrophysiology | POMT2 SPTBN4 CACNA1S UBA1 GALC ADRA2B SCN1A SCN2A SCN3A SCN4A SCN9A CACNA1H MED23 AGRN EMILIN1 PHGDH CHRNE | 3.66e-05 | 924 | 35 | 17 | HP:0001311 |
| HumanPheno | Myotonia with warm-up phenomenon | 4.59e-05 | 2 | 35 | 2 | HP:0003740 | |
| HumanPheno | Recurrent infections due to aspiration | 4.59e-05 | 2 | 35 | 2 | HP:0004891 | |
| HumanPheno | Limited neck range of motion | 4.72e-05 | 11 | 35 | 3 | HP:0000466 | |
| HumanPheno | Abnormality of jaw muscles | 5.15e-05 | 31 | 35 | 4 | HP:0045037 | |
| HumanPheno | Abnormality of the shoulder girdle musculature | 5.38e-05 | 149 | 35 | 7 | HP:0001435 | |
| HumanPheno | Feeding difficulties | POMT2 SPTBN4 CACNA1S UBA1 GALC PANK2 CLCN1 ACADVL SCN1A SCN3A SCN4A SCN9A EMG1 ELP1 CDC6 MED23 AGRN PHGDH CHRNE | 5.40e-05 | 1168 | 35 | 19 | HP:0011968 |
| HumanPheno | Limb-girdle muscle weakness | 5.96e-05 | 103 | 35 | 6 | HP:0003325 | |
| HumanPheno | Epilepsia partialis continua | 6.27e-05 | 12 | 35 | 3 | HP:0012847 | |
| HumanPheno | Myopathy | 6.42e-05 | 341 | 35 | 10 | HP:0003198 | |
| HumanPheno | Obsessive-compulsive trait | 6.64e-05 | 33 | 35 | 4 | HP:0008770 | |
| HumanPheno | Calcaneovalgus deformity | 7.48e-05 | 34 | 35 | 4 | HP:0001848 | |
| HumanPheno | Fatigable weakness of neck muscles | 8.11e-05 | 13 | 35 | 3 | HP:0030199 | |
| HumanPheno | Decreased miniature endplate potentials | 8.11e-05 | 13 | 35 | 3 | HP:0003402 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 8.11e-05 | 13 | 35 | 3 | HP:0007058 | |
| HumanPheno | Deformed tarsal bones | 8.41e-05 | 35 | 35 | 4 | HP:0008119 | |
| HumanPheno | Disturbance of facial expression | 9.41e-05 | 36 | 35 | 4 | HP:0005324 | |
| HumanPheno | EMG abnormality | 1.14e-04 | 293 | 35 | 9 | HP:0003457 | |
| HumanPheno | Decreased size of nerve terminals | 1.28e-04 | 15 | 35 | 3 | HP:0003443 | |
| HumanPheno | Facial tics | 1.28e-04 | 15 | 35 | 3 | HP:0011468 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 1.28e-04 | 15 | 35 | 3 | HP:0007207 | |
| HumanPheno | Hip flexor weakness | 1.28e-04 | 15 | 35 | 3 | HP:0012515 | |
| HumanPheno | Facial palsy | 1.33e-04 | 232 | 35 | 8 | HP:0010628 | |
| HumanPheno | Abnormal seventh cranial physiology | 1.37e-04 | 233 | 35 | 8 | HP:0010827 | |
| HumanPheno | Abnormal muscle fiber morphology | 1.44e-04 | 302 | 35 | 9 | HP:0004303 | |
| HumanPheno | Dysgenesis of the hippocampus | 1.57e-04 | 16 | 35 | 3 | HP:0025101 | |
| HumanPheno | Complex febrile seizure | 1.57e-04 | 16 | 35 | 3 | HP:0011172 | |
| HumanPheno | EEG abnormality | POMT2 SPTBN4 GALC ADRA2B SCN1A SCN2A SCN3A SCN9A CACNA1H MED23 AGRN PHGDH | 1.73e-04 | 548 | 35 | 12 | HP:0002353 |
| HumanPheno | Focal motor status epilepticus | 1.89e-04 | 17 | 35 | 3 | HP:0032663 | |
| HumanPheno | Ankle weakness | 1.89e-04 | 17 | 35 | 3 | HP:0031374 | |
| HumanPheno | Atypical absence status epilepticus | 1.89e-04 | 17 | 35 | 3 | HP:0011151 | |
| HumanPheno | Focal emotional seizure with laughing | 1.89e-04 | 17 | 35 | 3 | HP:0010821 | |
| HumanPheno | Visually-induced seizure | 2.26e-04 | 18 | 35 | 3 | HP:0020216 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 2.26e-04 | 18 | 35 | 3 | HP:0032860 | |
| HumanPheno | Focal emotional seizure | 2.26e-04 | 18 | 35 | 3 | HP:0025613 | |
| HumanPheno | Triceps weakness | 2.26e-04 | 18 | 35 | 3 | HP:0031108 | |
| HumanPheno | Fatigable weakness of skeletal muscles | 2.28e-04 | 45 | 35 | 4 | HP:0030197 | |
| HumanPheno | EEG with spike-wave complexes | 2.96e-04 | 88 | 35 | 5 | HP:0010850 | |
| HumanPheno | Weakness of long finger extensor muscles | 3.13e-04 | 20 | 35 | 3 | HP:0009077 | |
| HumanPheno | Non-convulsive status epilepticus without coma | 3.13e-04 | 20 | 35 | 3 | HP:0032671 | |
| HumanPheno | Weak cry | 3.18e-04 | 49 | 35 | 4 | HP:0001612 | |
| HumanPheno | Talipes valgus | 3.63e-04 | 21 | 35 | 3 | HP:0004684 | |
| HumanPheno | Weakness of facial musculature | 3.68e-04 | 269 | 35 | 8 | HP:0030319 | |
| HumanPheno | Pelvic girdle muscle weakness | 3.71e-04 | 51 | 35 | 4 | HP:0003749 | |
| HumanPheno | Infection-related seizure | 3.94e-04 | 145 | 35 | 6 | HP:0032892 | |
| HumanPheno | Seizure precipitated by febrile infection | 3.94e-04 | 145 | 35 | 6 | HP:0032894 | |
| HumanPheno | Febrile seizure (within the age range of 3 months to 6 years) | 3.94e-04 | 145 | 35 | 6 | HP:0002373 | |
| HumanPheno | Abnormal morphology of the pelvis musculature | 4.00e-04 | 52 | 35 | 4 | HP:0001469 | |
| HumanPheno | Abnormality of the hip-girdle musculature | 4.00e-04 | 52 | 35 | 4 | HP:0001445 | |
| HumanPheno | Anti-acetylcholine receptor antibody positivity | 4.19e-04 | 22 | 35 | 3 | HP:6001064 | |
| HumanPheno | Reflex seizure | 4.19e-04 | 22 | 35 | 3 | HP:0020207 | |
| HumanPheno | Anti-neuromuscular Junction acetylcholine receptor antibody positivity | 4.19e-04 | 22 | 35 | 3 | HP:0030208 | |
| HumanPheno | Tibial torsion | 4.79e-04 | 23 | 35 | 3 | HP:0100694 | |
| HumanPheno | Pes valgus | 5.33e-04 | 56 | 35 | 4 | HP:0008081 | |
| HumanPheno | Abnormal ankle morphology | 5.36e-04 | 100 | 35 | 5 | HP:0034673 | |
| HumanPheno | Weakness of the intrinsic hand muscles | 5.45e-04 | 24 | 35 | 3 | HP:0009005 | |
| HumanPheno | Thoracic kyphoscoliosis | 5.45e-04 | 24 | 35 | 3 | HP:0005659 | |
| HumanPheno | Abnormality of facial musculature | 5.51e-04 | 361 | 35 | 9 | HP:0000301 | |
| HumanPheno | Shoulder girdle muscle weakness | 5.70e-04 | 57 | 35 | 4 | HP:0003547 | |
| HumanPheno | Abnormality of the calcaneus | 5.70e-04 | 57 | 35 | 4 | HP:0008364 | |
| HumanPheno | Infantile muscular hypotonia | 5.92e-04 | 219 | 35 | 7 | HP:0008947 | |
| HumanPheno | Fatigable weakness of respiratory muscles | 6.09e-04 | 58 | 35 | 4 | HP:0030196 | |
| HumanPheno | Respiratory insufficiency due to muscle weakness | 6.15e-04 | 103 | 35 | 5 | HP:0002747 | |
| HumanPheno | Focal hemiclonic seizure | 6.16e-04 | 25 | 35 | 3 | HP:0006813 | |
| HumanPheno | Exercise-induced rhabdomyolysis | 6.76e-04 | 6 | 35 | 2 | HP:0009045 | |
| HumanPheno | Hypogeusia | 6.76e-04 | 6 | 35 | 2 | HP:0000224 | |
| HumanPheno | Episodic hypokalemia | 6.76e-04 | 6 | 35 | 2 | HP:0012726 | |
| HumanPheno | Handgrip myotonia | 6.76e-04 | 6 | 35 | 2 | HP:0012899 | |
| HumanPheno | Malignant hyperthermia | 6.93e-04 | 26 | 35 | 3 | HP:0002047 | |
| HumanPheno | Respiratory distress | 7.15e-04 | 226 | 35 | 7 | HP:0002098 | |
| HumanPheno | Abnormal cry | 7.38e-04 | 61 | 35 | 4 | HP:0025429 | |
| HumanPheno | Limited knee extension | 7.76e-04 | 27 | 35 | 3 | HP:0003066 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 7.76e-04 | 27 | 35 | 3 | HP:0031475 | |
| HumanPheno | Simple febrile seizure | 7.76e-04 | 27 | 35 | 3 | HP:0011171 | |
| HumanPheno | Mask-like facies | 7.96e-04 | 109 | 35 | 5 | HP:0000298 | |
| HumanPheno | Athetosis | 8.10e-04 | 166 | 35 | 6 | HP:0002305 | |
| HumanPheno | Focal aware seizure | 8.66e-04 | 28 | 35 | 3 | HP:0002349 | |
| HumanPheno | Episodic flaccid weakness | 9.43e-04 | 7 | 35 | 2 | HP:0003752 | |
| HumanPheno | Abnormality of taste sensation | 9.43e-04 | 7 | 35 | 2 | HP:0000223 | |
| HumanPheno | Status epilepticus with prominent motor symptoms | 9.61e-04 | 29 | 35 | 3 | HP:0032658 | |
| HumanPheno | Reduced vital capacity | 9.61e-04 | 29 | 35 | 3 | HP:0002792 | |
| HumanPheno | Weakness of muscles of respiration | 1.06e-03 | 116 | 35 | 5 | HP:0004347 | |
| HumanPheno | Abnormality of peripheral nervous system electrophysiology | 1.06e-03 | 315 | 35 | 8 | HP:0030177 | |
| HumanPheno | Progressive gait ataxia | 1.06e-03 | 30 | 35 | 3 | HP:0007240 | |
| HumanPheno | EMG: decremental response of compound muscle action potential to repetitive nerve stimulation | 1.06e-03 | 30 | 35 | 3 | HP:0003403 | |
| HumanPheno | Progressive ataxia | 1.06e-03 | 30 | 35 | 3 | HP:0001329 | |
| HumanPheno | Abnormal peripheral nervous system physiology | 1.15e-03 | 319 | 35 | 8 | HP:0032120 | |
| HumanPheno | Muscle spasm | 1.17e-03 | 178 | 35 | 6 | HP:0003394 | |
| HumanPheno | Myoglobinuria | 1.17e-03 | 31 | 35 | 3 | HP:0002913 | |
| HumanPheno | Abnormal shoulder morphology | 1.18e-03 | 246 | 35 | 7 | HP:0003043 | |
| HumanPheno | Abnormal circulating creatine kinase concentration | 1.22e-03 | 322 | 35 | 8 | HP:0040081 | |
| HumanPheno | Late-onset proximal muscle weakness | 1.25e-03 | 8 | 35 | 2 | HP:0003694 | |
| HumanPheno | Fatigable weakness | 1.28e-03 | 121 | 35 | 5 | HP:0003473 | |
| MousePheno | muscle twitch | 1.23e-06 | 64 | 76 | 6 | MP:0009046 | |
| MousePheno | impaired skeletal muscle contractility | 3.83e-06 | 44 | 76 | 5 | MP:0002841 | |
| MousePheno | abnormal muscle physiology | SPTBN4 CKM CACNA1S GALC ADRA2B SLC4A7 CLCN1 PPT2 ACADVL SYNM SGCB LPO SCN4A CACNA1H TNKS AGRN CHRNE | 1.08e-05 | 954 | 76 | 17 | MP:0002106 |
| MousePheno | abnormal muscle electrophysiology | 2.58e-05 | 32 | 76 | 4 | MP:0004145 | |
| MousePheno | paraparesis | 2.58e-05 | 32 | 76 | 4 | MP:0009434 | |
| MousePheno | hindlimb paresis | 4.65e-05 | 37 | 76 | 4 | MP:0031204 | |
| MousePheno | abnormal muscle contractility | SPTBN4 CKM CACNA1S ADRA2B SLC4A7 CLCN1 SYNM SCN4A CACNA1H CHRNE | 8.40e-05 | 418 | 76 | 10 | MP:0005620 |
| MousePheno | abnormal skeletal muscle morphology | CKM CACNA1S CLCN1 ACADVL SYNM SGCB SCN4A ELP1 AGRN FREM1 CHRNE | 8.84e-05 | 508 | 76 | 11 | MP:0000759 |
| MousePheno | abnormal skeletal muscle mass | 1.57e-04 | 149 | 76 | 6 | MP:0004817 | |
| MousePheno | paresis | 1.93e-04 | 53 | 76 | 4 | MP:0000754 | |
| MousePheno | myopathy | 2.08e-04 | 54 | 76 | 4 | MP:0000751 | |
| Domain | Na_channel_asu | 6.07e-10 | 10 | 91 | 5 | IPR001696 | |
| Domain | Na_trans_assoc | 6.07e-10 | 10 | 91 | 5 | IPR010526 | |
| Domain | Na_trans_assoc | 6.07e-10 | 10 | 91 | 5 | PF06512 | |
| Domain | Na_trans_cytopl | 7.85e-09 | 6 | 91 | 4 | PF11933 | |
| Domain | Na_trans_cytopl | 7.85e-09 | 6 | 91 | 4 | IPR024583 | |
| Domain | Channel_four-helix_dom | 1.12e-08 | 57 | 91 | 7 | IPR027359 | |
| Domain | - | 1.12e-08 | 57 | 91 | 7 | 1.20.120.350 | |
| Domain | Ion_trans_dom | 1.39e-06 | 114 | 91 | 7 | IPR005821 | |
| Domain | Ion_trans | 1.39e-06 | 114 | 91 | 7 | PF00520 | |
| Domain | IQ | 4.70e-05 | 81 | 91 | 5 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 7.79e-05 | 90 | 91 | 5 | IPR000048 | |
| Domain | IQ | 9.11e-05 | 93 | 91 | 5 | PS50096 | |
| Domain | ATP-gua_PtransN | 1.40e-04 | 4 | 91 | 2 | PF02807 | |
| Domain | PHOSPHAGEN_KINASE | 1.40e-04 | 4 | 91 | 2 | PS00112 | |
| Domain | ATP-guanido_PTrfase_N | 1.40e-04 | 4 | 91 | 2 | IPR022413 | |
| Domain | ATP-guanido_PTrfase_AS | 1.40e-04 | 4 | 91 | 2 | IPR022415 | |
| Domain | ATP-guanido_PTrfase_cat | 1.40e-04 | 4 | 91 | 2 | IPR022414 | |
| Domain | ATP-gua_Ptrans | 1.40e-04 | 4 | 91 | 2 | PF00217 | |
| Domain | - | 1.40e-04 | 4 | 91 | 2 | 1.10.135.10 | |
| Domain | PHOSPHAGEN_KINASE_N | 1.40e-04 | 4 | 91 | 2 | PS51509 | |
| Domain | PHOSPHAGEN_KINASE_C | 1.40e-04 | 4 | 91 | 2 | PS51510 | |
| Domain | ATP-guanido_PTrfase | 2.33e-04 | 5 | 91 | 2 | IPR000749 | |
| Domain | Gln_synth/guanido_kin_cat_dom | 3.48e-04 | 6 | 91 | 2 | IPR014746 | |
| Domain | Alpha/beta_knot_MTases | 3.48e-04 | 6 | 91 | 2 | IPR029028 | |
| Domain | - | 3.48e-04 | 6 | 91 | 2 | 3.30.590.10 | |
| Domain | IQ | 3.99e-04 | 71 | 91 | 4 | PF00612 | |
| Domain | LRR | 4.50e-04 | 201 | 91 | 6 | PS51450 | |
| Domain | ANION_EXCHANGER_2 | 4.85e-04 | 7 | 91 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 4.85e-04 | 7 | 91 | 2 | PS00219 | |
| Domain | LRR_1 | 7.06e-04 | 219 | 91 | 6 | PF00560 | |
| Domain | Band3_cytoplasmic_dom | 8.27e-04 | 9 | 91 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 8.27e-04 | 9 | 91 | 2 | PF07565 | |
| Domain | - | 8.27e-04 | 9 | 91 | 2 | 3.40.1100.10 | |
| Domain | HCO3_cotransp | 1.03e-03 | 10 | 91 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 1.03e-03 | 10 | 91 | 2 | IPR011531 | |
| Domain | PTrfase/Anion_transptr | 1.03e-03 | 10 | 91 | 2 | IPR016152 | |
| Domain | VDCCAlpha1 | 1.03e-03 | 10 | 91 | 2 | IPR002077 | |
| Domain | HCO3_transpt_euk | 1.03e-03 | 10 | 91 | 2 | IPR003020 | |
| Domain | - | 1.42e-03 | 169 | 91 | 5 | 3.40.50.720 | |
| Domain | NAD(P)-bd_dom | 1.57e-03 | 173 | 91 | 5 | IPR016040 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.74e-03 | 177 | 91 | 5 | IPR003591 | |
| Domain | LRR_TYP | 1.74e-03 | 177 | 91 | 5 | SM00369 | |
| Domain | ATPase_dyneun-rel_AAA | 2.06e-03 | 14 | 91 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.06e-03 | 14 | 91 | 2 | PF07728 | |
| Domain | Leu-rich_rpt | 2.10e-03 | 271 | 91 | 6 | IPR001611 | |
| Domain | - | 3.41e-03 | 18 | 91 | 2 | 3.30.470.20 | |
| Domain | - | 4.83e-03 | 321 | 91 | 6 | 3.80.10.10 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.13e-08 | 31 | 74 | 6 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 6.27e-07 | 32 | 74 | 5 | M27455 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.06e-05 | 121 | 74 | 6 | M872 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.30e-04 | 63 | 74 | 4 | M11187 | |
| Pathway | WP_DRAVET_SYNDROME | 4.14e-04 | 28 | 74 | 3 | M45519 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 4.60e-04 | 29 | 74 | 3 | MM14802 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CREATINE_PATHWAY | 5.61e-04 | 7 | 74 | 2 | M47940 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 5.62e-04 | 31 | 74 | 3 | M685 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 5.98e-04 | 130 | 74 | 5 | M27454 | |
| Pathway | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | 6.17e-04 | 32 | 74 | 3 | MM15446 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 6.80e-04 | 203 | 74 | 6 | M5485 | |
| Pathway | REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION | 7.46e-04 | 8 | 74 | 2 | M26991 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | SPTBN4 CACNA1S SCN1A SCN2A SCN3A SCN4A SCN9A GRB7 CACNA1H AGRN | 8.06e-04 | 575 | 74 | 10 | M29853 |
| Pathway | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | 9.49e-04 | 37 | 74 | 3 | M729 | |
| Pubmed | 1.53e-11 | 9 | 93 | 5 | 16382098 | ||
| Pubmed | 2.39e-10 | 5 | 93 | 4 | 8812438 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 7.16e-10 | 6 | 93 | 4 | 23652591 | |
| Pubmed | 5.97e-09 | 9 | 93 | 4 | 15746173 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 19284629 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 12610651 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 33895391 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 23859570 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 18784617 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 17544618 | ||
| Pubmed | Mutation spectrum and health status in skeletal muscle channelopathies in Japan. | 1.85e-08 | 3 | 93 | 3 | 32660787 | |
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 14973256 | ||
| Pubmed | 3.36e-08 | 13 | 93 | 4 | 15123669 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 17537961 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 35031483 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 29578003 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 35801810 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 7.39e-08 | 4 | 93 | 3 | 8974318 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 9.95e-08 | 139 | 93 | 7 | 16985003 | |
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 1679748 | ||
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 17724025 | ||
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 24337656 | ||
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 24105479 | ||
| Pubmed | 7.15e-07 | 484 | 93 | 10 | 31995728 | ||
| Pubmed | CKB PDIA6 UBA1 DIS3L2 ACADVL ACLY SCN2A EMG1 KDM5D AGRN PHGDH DHX9 | 1.59e-06 | 803 | 93 | 12 | 36517590 | |
| Pubmed | Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis. | 3.20e-06 | 84 | 93 | 5 | 19135240 | |
| Pubmed | 4.00e-06 | 12 | 93 | 3 | 8169823 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 4.00e-06 | 12 | 93 | 3 | 30175250 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 29649454 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 19337554 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 20346423 | ||
| Pubmed | Dissimilarity in the folding of human cytosolic creatine kinase isoenzymes. | 7.07e-06 | 2 | 93 | 2 | 21931810 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 18079277 | ||
| Pubmed | Redefining the clinical phenotypes of non-dystrophic myotonic syndromes. | 7.07e-06 | 2 | 93 | 2 | 19211598 | |
| Pubmed | A novel murine myotonia congenita without molecular defects in the ClC-1 and the SCN4A. | 7.07e-06 | 2 | 93 | 2 | 12370472 | |
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 7.07e-06 | 2 | 93 | 2 | 10827969 | |
| Pubmed | Sequence CLCN1 and SCN4A genes in patients with nondystrophic myotonia in Chinese people. | 7.07e-06 | 2 | 93 | 2 | 35866763 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 19694741 | ||
| Pubmed | Myocardial creatine kinase expression after left ventricular assist device support. | 7.07e-06 | 2 | 93 | 2 | 12039490 | |
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 7.07e-06 | 2 | 93 | 2 | 11245985 | |
| Pubmed | A novel founder SCN4A mutation causes painful cold-induced myotonia in French-Canadians. | 7.07e-06 | 2 | 93 | 2 | 17998485 | |
| Pubmed | Creatine kinase transcript accumulation: effect of nerve during muscle development. | 7.07e-06 | 2 | 93 | 2 | 10417818 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 9748661 | ||
| Pubmed | Localization of a human brain sodium channel gene (SCN2A) to chromosome 2. | 7.07e-06 | 2 | 93 | 2 | 2571571 | |
| Pubmed | Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis. | 7.07e-06 | 2 | 93 | 2 | 15072700 | |
| Pubmed | Exploring the role of the active site cysteine in human muscle creatine kinase. | 7.07e-06 | 2 | 93 | 2 | 16981706 | |
| Pubmed | Creatine kinase activity in normal and Duchenne muscular dystrophy fibroblasts. | 7.07e-06 | 2 | 93 | 2 | 7057800 | |
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 7.07e-06 | 2 | 93 | 2 | 1317301 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 7808454 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 7808458 | ||
| Pubmed | A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. | 7.07e-06 | 2 | 93 | 2 | 10520990 | |
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 7.07e-06 | 2 | 93 | 2 | 23016767 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 27153334 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 33096315 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 18337730 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 7.07e-06 | 2 | 93 | 2 | 24990319 | |
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 7.07e-06 | 2 | 93 | 2 | 25172946 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 23417379 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 31439038 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 15304505 | ||
| Pubmed | Mutation analysis of CACNA1S and SCN4A in patients with hypokalemic periodic paralysis. | 7.07e-06 | 2 | 93 | 2 | 26252573 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 22475533 | ||
| Pubmed | Myotonia congenita: mutation spectrum of CLCN1 in Spanish patients. | 7.07e-06 | 2 | 93 | 2 | 31544778 | |
| Pubmed | Non-dystrophic myotonia Chilean cohort with predominance of the SCN4A Gly1306Glu variant. | 7.07e-06 | 2 | 93 | 2 | 32593548 | |
| Pubmed | Diagnostic significance of total creatine kinase and its isoform in tubal ectopic pregnancy. | 7.07e-06 | 2 | 93 | 2 | 23876027 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 26311622 | ||
| Pubmed | Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. | 7.07e-06 | 2 | 93 | 2 | 19118277 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 35759432 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 33670307 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 23886516 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 7.07e-06 | 2 | 93 | 2 | 15249644 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 27690330 | ||
| Pubmed | Non-dystrophic myotonia: prospective study of objective and patient reported outcomes. | 7.07e-06 | 2 | 93 | 2 | 23771340 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 21377452 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 36720299 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 34608571 | ||
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 7.07e-06 | 2 | 93 | 2 | 23965409 | |
| Pubmed | Genotype and phenotype analysis of patients with sporadic periodic paralysis. | 7.07e-06 | 2 | 93 | 2 | 21841462 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 33040644 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 27415035 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 30693367 | ||
| Pubmed | The mechanism underlying transient weakness in myotonia congenita. | 7.07e-06 | 2 | 93 | 2 | 33904400 | |
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 8.23e-06 | 15 | 93 | 3 | 9726281 | |
| Pubmed | 1.12e-05 | 186 | 93 | 6 | 14744259 | ||
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 1.47e-05 | 18 | 93 | 3 | 12023983 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 28784306 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 32185219 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 32005694 | ||
| Pubmed | Population genetic implications from sequence variation in four Y chromosome genes. | 2.12e-05 | 3 | 93 | 2 | 10861003 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 21281598 | ||
| Pubmed | Assignment of a locus for autosomal dominant idiopathic scoliosis (IS) to human chromosome 17p11. | 2.12e-05 | 3 | 93 | 2 | 12384783 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 19699781 | ||
| Pubmed | Regulation of the human NBC3 Na+/HCO3- cotransporter by carbonic anhydrase II and PKA. | 2.12e-05 | 3 | 93 | 2 | 14736710 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 32845893 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 16033895 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 20038812 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 28518218 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 27816501 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 19270815 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 20301512 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 1.35e-04 | 127 | 93 | 4 | chr2q24 | |
| Cytoband | 2q24 | 2.21e-04 | 11 | 93 | 2 | 2q24 | |
| Cytoband | Yq11 | 2.64e-04 | 12 | 93 | 2 | Yq11 | |
| Cytoband | 2q24.3 | 4.78e-04 | 16 | 93 | 2 | 2q24.3 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 5.01e-11 | 9 | 62 | 5 | 1203 | |
| GeneFamily | SPOUT methyltranferase domain containing | 3.20e-04 | 8 | 62 | 2 | 1294 | |
| GeneFamily | PDZ domain containing | 1.83e-03 | 152 | 62 | 4 | 1220 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 3.04e-03 | 24 | 62 | 2 | 485 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.57e-03 | 26 | 62 | 2 | 253 | |
| Coexpression | MIKKELSEN_MEF_ICP_WITH_H3K27ME3 | 9.23e-06 | 207 | 93 | 7 | M1963 | |
| Coexpression | MIKKELSEN_MEF_ICP_WITH_H3K27ME3 | 1.50e-05 | 223 | 93 | 7 | MM838 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-06 | 158 | 93 | 6 | ab707bfe782c667b252b488ad1d7efd49cf0a899 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 1.30e-06 | 165 | 93 | 6 | 7b992843bd8ef92a7a76b1d681fa84efde6f5bdd | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-06 | 189 | 93 | 6 | b28a0e2d5a5f512f9b137b162b195bdc3d5ee9ba | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-06 | 195 | 93 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-06 | 195 | 93 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | LAM-Endothelial-LymEndo|Endothelial / Condition, Lineage and Cell class | 3.73e-06 | 198 | 93 | 6 | ba64b1c95dfaa995045239d412e725596f6c482e | |
| ToppCell | Endothelial-G|World / shred on cell class and cell subclass (v4) | 6.28e-06 | 124 | 93 | 5 | 4b72809463f2986b7d1b7ab9de633ac4d7854a92 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 1.53e-05 | 149 | 93 | 5 | d7f1069f70f3cad6d3700ee2041ed1d4cb7c49ab | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 159 | 93 | 5 | e967b557fe6ae4879d36f62c0297cbf6a2ad1ce9 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 159 | 93 | 5 | 9db971130509c62d439e0cab16588a4d994d7aa0 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-05 | 162 | 93 | 5 | 8a488ecd25ef41468c3c7766eb936dbc2f7665a9 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_dendritic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.29e-05 | 162 | 93 | 5 | 233011408f022647932c81ebab78f9813e3c6833 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 164 | 93 | 5 | a67dd181eba275c191f4d0cab13df30eaa3ad913 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.50e-05 | 165 | 93 | 5 | 347b59aa625a8a960828b8620824d8ac48990e07 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.50e-05 | 165 | 93 | 5 | 507c89ece0a336b8e9c65b79889a714e17ddca27 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.50e-05 | 165 | 93 | 5 | 39a25be081a5d59c7cf107a997d352793d5025fb | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.50e-05 | 165 | 93 | 5 | 1890f9c33b0c5b381d57f97042da2610a093a6de | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.73e-05 | 168 | 93 | 5 | d6078e3a79d315d6090906e171a7d67a9206b2c7 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.73e-05 | 168 | 93 | 5 | 99148986aa5628f67d85258c171b254be77a071c | |
| ToppCell | Healthy_Control-Lymphoid-pDC|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.80e-05 | 169 | 93 | 5 | a4e9b8b2f0338203455ba941b8f99bf4884d26f0 | |
| ToppCell | Healthy_Control-Lymphoid-pDC-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.80e-05 | 169 | 93 | 5 | 338ce99897cb522b86edd603f75bc15ec4dfcda3 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.88e-05 | 170 | 93 | 5 | bf589c4297ccc90e5f51e3d0fcc229548af4fcef | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.97e-05 | 171 | 93 | 5 | 38a05b5ec8ef8f09a2399994c6b4b9a707918ec1 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.22e-05 | 174 | 93 | 5 | 9f114e61458659005b6d0b4aa30a7a059e7aa5c6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-05 | 175 | 93 | 5 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-05 | 183 | 93 | 5 | b5782b18decfe85026acf42daac0670d92385861 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 4.10e-05 | 183 | 93 | 5 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-05 | 183 | 93 | 5 | e32847cfebba7c8bb2026e33c3c85f64819460a9 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-05 | 187 | 93 | 5 | f491ec986dd44e2dabdf4a75c3101e3b6c921872 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 187 | 93 | 5 | 85e58a312fc325e4063a2d250666b99b8f99beb6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 187 | 93 | 5 | 52b5b38bef3cc06487cf42c6fb22fb33f0c7ce2b | |
| ToppCell | RV-07._Pericyte|World / Chamber and Cluster_Paper | 4.54e-05 | 187 | 93 | 5 | dc274d6bbda619a2c914d84e2b4069cfef1739d1 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-05 | 187 | 93 | 5 | 8ff9f771d10c372d771c92dfa9006aa81aec4681 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-05 | 187 | 93 | 5 | 96dc5dc4dbc1b33c2e66666e9027cfbf7972090b | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 188 | 93 | 5 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 190 | 93 | 5 | a1b5775a21d42633224b7d348f0d12b0589dad12 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-05 | 191 | 93 | 5 | c8b99bd3a30c81ee4deba9cbf0196920ab3ab550 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-parabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-05 | 192 | 93 | 5 | c7185fbc56ffd4c62db47fc240b3207ef65db40e | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 193 | 93 | 5 | 2483bb7f398e4fa0ef09c8bd584ed25703853f03 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.54e-05 | 195 | 93 | 5 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.54e-05 | 195 | 93 | 5 | 58b769da05a8f6b05aeb08d4f8b112941087ad00 | |
| ToppCell | (08)_PNEC|World / shred by cell type and Timepoint | 5.68e-05 | 196 | 93 | 5 | 2ee37155c03cd5009427a4bffe6c80ed2ac6939e | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Serous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.82e-05 | 197 | 93 | 5 | 92a66e3b5ddc3d55527c31e0d9cff15c2203ecfc | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.96e-05 | 198 | 93 | 5 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | distal-mesenchymal-Myofibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.96e-05 | 198 | 93 | 5 | beef5075ba6dcd4d0a447bc4e57efcaf2e93c546 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.96e-05 | 198 | 93 | 5 | 54c8aa47040bc4977eed382514fc4ceae03f54f8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.96e-05 | 198 | 93 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.10e-05 | 199 | 93 | 5 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.10e-05 | 199 | 93 | 5 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.10e-05 | 199 | 93 | 5 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | COVID-19-COVID-19_Severe-Others-HSPC|COVID-19_Severe / Disease, condition lineage and cell class | 6.10e-05 | 199 | 93 | 5 | 25de67b6c9c8d6bb9a538e071a40ef865906c95d | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.10e-05 | 199 | 93 | 5 | 2c5ad62919c64ea0242e0984bb9932d2d975f4e3 | |
| ToppCell | COVID-19-COVID-19_Mild-Others-HSPC|COVID-19_Mild / Disease, condition lineage and cell class | 6.10e-05 | 199 | 93 | 5 | 0230103c37ae3aff58240739b89f2c36b1e39a69 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.10e-05 | 199 | 93 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.25e-05 | 200 | 93 | 5 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-ILC|Multiple_Sclerosis / Disease, condition lineage and cell class | 6.25e-05 | 200 | 93 | 5 | ab9bdc9365cbdffe4ed246ce0c8a008a390e387e | |
| ToppCell | distal-mesenchymal-Myofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.25e-05 | 200 | 93 | 5 | 61854a459385cd9295be37157a8f81a2c227dff3 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 122 | 93 | 4 | 8f675dc341b3f6e22f7e52c34d167d9e37df0982 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 122 | 93 | 4 | c7e81504e62d132624ec15b7d38dc5b6493a37a4 | |
| ToppCell | droplet-Skin-nan-18m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 125 | 93 | 4 | 5a309ce803d2b8efd791eb21808121bf5fc3ea8e | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-2|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.46e-04 | 127 | 93 | 4 | 018ffd9ff1913787cb0086a8581b399a121eaba1 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Sc17a7.Tshz2-Smoc1_(Agranular_Retrosplenial_cortex_(RSG)_(Smoc1+))-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.47e-04 | 49 | 93 | 3 | 4845246699a56fea657fd2697b612e93248f590f | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Sc17a7.Tshz2-Smoc1_(Agranular_Retrosplenial_cortex_(RSG)_(Smoc1+))|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.47e-04 | 49 | 93 | 3 | 5f1c5ebb6f113513b7e6945dfab07c3c34ebab41 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.79e-04 | 134 | 93 | 4 | b959899c89d3a0363a3cd2309155280e0fe5ba88 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Cdh13|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.89e-04 | 136 | 93 | 4 | 1f3000d5f105c87c80f8ae1dd2264bcd7f757a9c | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.29e-04 | 143 | 93 | 4 | b4ed3855652fdf32f97cb7c18cab4f4f4c24d5c7 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.36e-04 | 144 | 93 | 4 | f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.36e-04 | 144 | 93 | 4 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-04 | 146 | 93 | 4 | cffa91d76606f74553d81150adbb23b003746316 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.55e-04 | 147 | 93 | 4 | 8f725ff8fb4ced5db2643e80669d3f7945b820ab | |
| ToppCell | 356C-Myeloid-Mast_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-04 | 148 | 93 | 4 | 1668d8a9e680da335362744f36b05446c499347e | |
| ToppCell | 356C-Myeloid-Mast_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-04 | 148 | 93 | 4 | 18511ba10765eda937c5a710626361f7e6b9b321 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor|bone_marrow / Manually curated celltypes from each tissue | 2.68e-04 | 149 | 93 | 4 | 078e1e5765e476ba85c23fb8f6892b6698cbcbdb | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C-8|TCGA-Thymus / Sample_Type by Project: Shred V9 | 3.12e-04 | 155 | 93 | 4 | 00eef9f93a753a1fe1ab5fd8dae026e7be556cde | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-04 | 157 | 93 | 4 | 0fecc14959c4c9efc19d5c06475a890e0a30f148 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.60e-04 | 161 | 93 | 4 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.60e-04 | 161 | 93 | 4 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.60e-04 | 161 | 93 | 4 | 7af3b0d4fc7967f6b3e2d255d23fd8b1fd01a7af | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.60e-04 | 161 | 93 | 4 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-1|TCGA-Kidney / Sample_Type by Project: Shred V9 | 3.60e-04 | 161 | 93 | 4 | 6cacae4a759ace763597ee394cff498dc5d96f74 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.60e-04 | 161 | 93 | 4 | 98be0cf8228496b31f7f3e0efd8787e95eb626d1 | |
| ToppCell | Control-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 3.69e-04 | 162 | 93 | 4 | e3b9b46ce2faff7d099502df14bbf51e9f183f8c | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 162 | 93 | 4 | 7f425a3983325a5a3ea33f812b15aa010cc55de0 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.69e-04 | 162 | 93 | 4 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | Control-Epithelial-Ionocyte|Control / Disease state, Lineage and Cell class | 3.77e-04 | 163 | 93 | 4 | bf09fa39bf3e6b3a776d5e79c30c96df572956a3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-04 | 165 | 93 | 4 | 9bd332e5ede759a00a47728ea5558c215efdd77a | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-04 | 165 | 93 | 4 | 36415924d05373e9dd3665be599f4f3f40bf0497 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.95e-04 | 165 | 93 | 4 | 1c630f9ecde2e0243922a2be4b1ab5adcfcb0893 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-04 | 165 | 93 | 4 | 56310fddd3d8e4afdfde066d26cee9747e5b8c6a | |
| ToppCell | COVID-19_Mild-PLT_0|COVID-19_Mild / Disease Group and Platelet Clusters | 3.95e-04 | 165 | 93 | 4 | 083a14d3b0162cee4e79f7398b8fb739582b39ff | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-04 | 166 | 93 | 4 | c215c4aede38d355d35fd26cd7ef2c19efecd0e6 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.13e-04 | 167 | 93 | 4 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.13e-04 | 167 | 93 | 4 | 9526e2c7673d569d04e0728a2526318e67432e0a | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 4.13e-04 | 167 | 93 | 4 | cb396f3edb9e8fdc316091e8e193dbba50e0be0c | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 168 | 93 | 4 | 2c996d09b6a8ccd3c708146eca310b02eafff425 | |
| ToppCell | facs-MAT-Fat-24m-Lymphocytic-T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 168 | 93 | 4 | 22fa707689e8d6ca5154103b7374007d644d61c3 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 168 | 93 | 4 | 96f7411474edd673b8d3ee6b8a8bb185c246daaf | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.32e-04 | 169 | 93 | 4 | b2d53159e344fad6fcdc485d5b8f6cf1bf094b1f | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.32e-04 | 169 | 93 | 4 | 7cb1b87be66a22fe5731bb1b55bc515920fe3e8b | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-04 | 169 | 93 | 4 | 46f0f0de9a0894c454f93032e7a7a800f47c8276 | |
| Drug | Zonisamide | 4.71e-11 | 17 | 93 | 6 | DB00909 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 6.60e-08 | 3 | 93 | 3 | ctd:C561228 | |
| Drug | Scorpion Venoms | 7.64e-07 | 18 | 93 | 4 | ctd:D012604 | |
| Drug | bepridil | 8.58e-07 | 126 | 93 | 7 | CID000002351 | |
| Drug | APETx1, Anthopleura elegantissima | 1.31e-06 | 6 | 93 | 3 | ctd:C475726 | |
| Drug | procaine | 3.15e-06 | 153 | 93 | 7 | CID000004914 | |
| Drug | verapamil | CKB CKM CACNA1S AP1AR ADRA2B SCN3A SCN4A SCN9A CACNA1H TAP2 CHRNE | 5.10e-06 | 490 | 93 | 11 | CID000002520 |
| Drug | AC1L1CQC | 6.94e-06 | 65 | 93 | 5 | CID000002012 | |
| Drug | disopyramide | 7.49e-06 | 66 | 93 | 5 | CID000003114 | |
| Drug | lamotrigine | 8.16e-06 | 116 | 93 | 6 | CID000003878 | |
| Drug | fenfluramine | 8.53e-06 | 178 | 93 | 7 | CID000003337 | |
| Drug | NSC7524 | 9.86e-06 | 182 | 93 | 7 | CID000005657 | |
| Drug | 2-hydroxyglutarate | 1.10e-05 | 34 | 93 | 4 | CID000000043 | |
| Drug | benzocaine | 1.55e-05 | 37 | 93 | 4 | CID000002337 | |
| Drug | mu-conotoxin KIIIA, Conus kinoshitai | 1.65e-05 | 2 | 93 | 2 | ctd:C502265 | |
| Drug | propionyl-L-carnitine | 1.73e-05 | 38 | 93 | 4 | CID000107738 | |
| Drug | estradiol, USP; Down 200; 0.01uM; PC3; HG-U133A | 1.82e-05 | 200 | 93 | 7 | 665_DN | |
| Drug | bupropion | 2.05e-05 | 81 | 93 | 5 | CID000000444 | |
| Drug | noradrealine | CKB CKM CACNA1S ADRA2B ACACA SYNM SGCB TNFAIP8L1 CACNA1H TAP2 CHRNE | 2.27e-05 | 575 | 93 | 11 | CID000000951 |
| Drug | sodium | CKB CKM CACNA1S SLC4A7 SLC4A8 SCN2A SCN3A SCN4A SCN9A ZFR CACNA1H HS3ST3A1 TAP2 CHRNE | 2.83e-05 | 944 | 93 | 14 | CID000000923 |
| Drug | nonanol | 2.90e-05 | 15 | 93 | 3 | CID000008914 | |
| Drug | salbutamol | 3.02e-05 | 146 | 93 | 6 | CID000002083 | |
| Drug | quindine | 3.25e-05 | 219 | 93 | 7 | CID000001065 | |
| Drug | pilsicainide | 3.73e-05 | 46 | 93 | 4 | CID000004820 | |
| Drug | Ketone Bodies | CKB DPP7 SPTBN4 CLCN1 ACACA AVPR1B SCN1A CDK5RAP2 AGRN ANAPC4 | 5.42e-05 | 522 | 93 | 10 | ctd:D007657 |
| Drug | isradipine | 5.66e-05 | 100 | 93 | 5 | CID000003784 | |
| Drug | forskolin from Coleus forskohlii | CKB GALC ADRA2B IGFALS AVPR1B SGCB ACLY SCN3A SCN4A SCN9A TNFAIP8L1 ZFR CDC6 CHRNE | 6.09e-05 | 1013 | 93 | 14 | CID000003413 |
| Drug | diprafenone | 6.10e-05 | 19 | 93 | 3 | CID000071249 | |
| Drug | phenylpropionic acid | 6.40e-05 | 167 | 93 | 6 | CID000000107 | |
| Drug | sakyomicin A | 7.06e-05 | 54 | 93 | 4 | CID000124041 | |
| Drug | pyraclofos | 7.47e-05 | 106 | 93 | 5 | CID000093460 | |
| Drug | oleoyl-estrone | 7.59e-05 | 55 | 93 | 4 | ctd:C108709 | |
| Drug | acetazolamide | 7.81e-05 | 107 | 93 | 5 | CID000001986 | |
| Drug | isoproterenol | CKB CKM ADRA2B CLCN1 AVPR1B SGCB SCN3A SCN4A SCN9A ELP1 TNFAIP8L1 | 8.90e-05 | 669 | 93 | 11 | CID000003779 |
| Drug | Propofol | 9.85e-05 | 4 | 93 | 2 | DB00818 | |
| Drug | Fospropofol | 9.85e-05 | 4 | 93 | 2 | DB06716 | |
| Drug | McN-5691 | 9.85e-05 | 4 | 93 | 2 | CID000127269 | |
| Drug | strychnine HCl | 9.99e-05 | 181 | 93 | 6 | CID000005304 | |
| Drug | Mn-protoporphyrin | 1.00e-04 | 59 | 93 | 4 | CID000159910 | |
| Drug | Lowicryl HM20 | 1.10e-04 | 23 | 93 | 3 | CID000174488 | |
| Drug | AC1NBU2S | 1.19e-04 | 117 | 93 | 5 | CID004473765 | |
| Drug | zonisamide | 1.21e-04 | 62 | 93 | 4 | CID000005734 | |
| Drug | propofol | 1.34e-04 | 191 | 93 | 6 | CID000004943 | |
| Drug | hydrochlorothiazide | 1.34e-04 | 120 | 93 | 5 | CID000003639 | |
| Drug | succinylcholine | 1.37e-04 | 64 | 93 | 4 | CID000005314 | |
| Drug | AC1NT1AF | 1.42e-04 | 25 | 93 | 3 | CID005322157 | |
| Drug | Multicide | 1.42e-04 | 25 | 93 | 3 | CID000024365 | |
| Drug | saxitoxin | 1.46e-04 | 65 | 93 | 4 | CID000037165 | |
| Drug | CDK2 Inhibitor II | 1.46e-04 | 65 | 93 | 4 | CID005858639 | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; PC3; HT_HG-U133A | 1.50e-04 | 195 | 93 | 6 | 4313_UP | |
| Drug | Propylthiouracil [51-52-5]; Down 200; 23.4uM; HL60; HT_HG-U133A | 1.54e-04 | 196 | 93 | 6 | 2476_DN | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 1.59e-04 | 197 | 93 | 6 | 2761_UP | |
| Drug | Pirmenolum | 1.60e-04 | 26 | 93 | 3 | CID000004853 | |
| Drug | ATP gamma-(N-(2-chloroethyl)-N-methyl)amide | 1.64e-04 | 5 | 93 | 2 | CID000174813 | |
| Drug | epoxycreatine | 1.64e-04 | 5 | 93 | 2 | CID000194341 | |
| Drug | gamma-benzylamide ATP | 1.64e-04 | 5 | 93 | 2 | CID000194049 | |
| Drug | vitamin K1 diacetate | 1.64e-04 | 5 | 93 | 2 | CID006441272 | |
| Drug | ATP gamma-p-azidoanilide | 1.64e-04 | 5 | 93 | 2 | CID003035480 | |
| Drug | homocyclocreatine | 1.64e-04 | 5 | 93 | 2 | CID000128636 | |
| Drug | N-2-hydroxyethyl-N-methyl-gamma-amide ATP | 1.64e-04 | 5 | 93 | 2 | CID000195952 | |
| Drug | steroid U | 1.64e-04 | 5 | 93 | 2 | CID000133659 | |
| Drug | gamma-anilide ATP | 1.64e-04 | 5 | 93 | 2 | CID000193883 | |
| Drug | aldimine | 1.64e-04 | 67 | 93 | 4 | CID000123139 | |
| Drug | Dipyrone [5907-38-0]; Up 200; 12uM; PC3; HT_HG-U133A | 1.68e-04 | 199 | 93 | 6 | 3754_UP | |
| Drug | PbTx-1 | 1.80e-04 | 27 | 93 | 3 | CID006437089 | |
| Drug | AC1L1MOZ | 1.80e-04 | 27 | 93 | 3 | CID000031958 | |
| Drug | nefopam | 1.80e-04 | 27 | 93 | 3 | CID000004450 | |
| Drug | To 2 | 1.84e-04 | 69 | 93 | 4 | CID000084102 | |
| Drug | periodic acid | 1.97e-04 | 205 | 93 | 6 | CID000065185 | |
| Drug | paraben | 2.01e-04 | 28 | 93 | 3 | CID000007175 | |
| Drug | nicorandil | 2.06e-04 | 71 | 93 | 4 | CID000047528 | |
| Drug | imide | 2.41e-04 | 74 | 93 | 4 | CID000443040 | |
| Drug | phosphocyclocreatine | 2.45e-04 | 6 | 93 | 2 | CID000124896 | |
| Drug | Creatine | 2.45e-04 | 6 | 93 | 2 | DB00148 | |
| Drug | CoADP | 2.45e-04 | 6 | 93 | 2 | CID000194171 | |
| Drug | PTMSA | 2.45e-04 | 6 | 93 | 2 | CID000006934 | |
| Drug | diaminochlorotriazine | 2.45e-04 | 6 | 93 | 2 | ctd:C526766 | |
| Drug | fenpropathrin | 2.45e-04 | 6 | 93 | 2 | ctd:C044267 | |
| Drug | AC1NUQ1J | 2.45e-04 | 6 | 93 | 2 | CID005458203 | |
| Drug | hexahydro-4-methyl phthalic anhydride | 2.45e-04 | 6 | 93 | 2 | CID000086876 | |
| Drug | tocainide | 2.47e-04 | 30 | 93 | 3 | CID000038945 | |
| Drug | oxcarbazepine | 2.47e-04 | 30 | 93 | 3 | CID000034312 | |
| Drug | ethylmalonic acid | 2.47e-04 | 30 | 93 | 3 | CID000011756 | |
| Drug | M-HN | 2.73e-04 | 31 | 93 | 3 | CID000015450 | |
| Drug | phenytoin | 2.81e-04 | 219 | 93 | 6 | CID000001775 | |
| Drug | iridium | 2.95e-04 | 78 | 93 | 4 | CID000023924 | |
| Drug | NSC93767 | 3.00e-04 | 32 | 93 | 3 | CID000005658 | |
| Drug | AC1L1BQX | 3.10e-04 | 79 | 93 | 4 | CID000001565 | |
| Drug | adenosine 3',5'-cyclic phosphate | CKB CKM CACNA1S GALC ADRA2B CLCN1 ACACA SYNM AVPR1B SGCB TNFAIP8L1 ZFR | 3.19e-04 | 907 | 93 | 12 | CID000000274 |
| Drug | gemcadiol | 3.42e-04 | 7 | 93 | 2 | CID000037147 | |
| Drug | AC1L1YAP | 3.42e-04 | 7 | 93 | 2 | CID000063066 | |
| Drug | Isradipine | 3.42e-04 | 7 | 93 | 2 | DB00270 | |
| Drug | fluorocyclobutane | 3.42e-04 | 7 | 93 | 2 | CID011051569 | |
| Drug | 2-nitrobenzenesulphonyl fluoride | 3.42e-04 | 7 | 93 | 2 | CID000097375 | |
| Drug | 1-carboxymethyl-2-iminohexahydropyrimidine | 3.42e-04 | 7 | 93 | 2 | CID000193725 | |
| Drug | 5-hydroxypropafenone | 3.60e-04 | 34 | 93 | 3 | CID000107927 | |
| Drug | trimetazidine | 3.60e-04 | 34 | 93 | 3 | CID000021109 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 6.94e-11 | 10 | 93 | 5 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 6.94e-11 | 10 | 93 | 5 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.17e-10 | 12 | 93 | 5 | DOID:0060170 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 6.48e-07 | 22 | 93 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 2.51e-06 | 9 | 93 | 3 | C3502809 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 8.47e-06 | 13 | 93 | 3 | C0751122 | |
| Disease | HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1 | 9.83e-06 | 2 | 93 | 2 | 170400 | |
| Disease | Hypokalemic periodic paralysis, type 1 | 9.83e-06 | 2 | 93 | 2 | cv:C3714580 | |
| Disease | Myotonia Congenita | 9.83e-06 | 2 | 93 | 2 | C0027127 | |
| Disease | Myotonia Levior | 9.83e-06 | 2 | 93 | 2 | C0270959 | |
| Disease | Hypokalemic periodic paralysis | 9.83e-06 | 2 | 93 | 2 | cv:C0238358 | |
| Disease | Becker Generalized Myotonia | 9.83e-06 | 2 | 93 | 2 | C0751360 | |
| Disease | Generalized Myotonia of Thomsen | 9.83e-06 | 2 | 93 | 2 | C2936781 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 9.83e-06 | 2 | 93 | 2 | C4551549 | |
| Disease | epilepsy (implicated_via_orthology) | 1.33e-05 | 163 | 93 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Hyperkalemic periodic paralysis | 2.94e-05 | 3 | 93 | 2 | C0238357 | |
| Disease | Hypokalemic periodic paralysis type 1 | 2.94e-05 | 3 | 93 | 2 | C3714580 | |
| Disease | Hypokalemic periodic paralysis | 5.87e-05 | 4 | 93 | 2 | C0238358 | |
| Disease | Myotonia | 1.46e-04 | 6 | 93 | 2 | C0027125 | |
| Disease | Epilepsy, Generalized | 1.46e-04 | 6 | 93 | 2 | C0014548 | |
| Disease | Seizure, Febrile, Simple | 2.04e-04 | 7 | 93 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 2.04e-04 | 7 | 93 | 2 | C0751057 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 2.72e-04 | 8 | 93 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 2.72e-04 | 8 | 93 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 2.72e-04 | 8 | 93 | 2 | C0338479 | |
| Disease | Myoclonic Encephalopathy | 2.72e-04 | 8 | 93 | 2 | C0438414 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 2.72e-04 | 8 | 93 | 2 | C0751120 | |
| Disease | hypokalemic periodic paralysis (implicated_via_orthology) | 2.72e-04 | 8 | 93 | 2 | DOID:14452 (implicated_via_orthology) | |
| Disease | Myoclonic Absence Epilepsy | 2.72e-04 | 8 | 93 | 2 | C0393703 | |
| Disease | Febrile Convulsions | 3.49e-04 | 9 | 93 | 2 | C0009952 | |
| Disease | Myoclonic Epilepsy | 3.49e-04 | 9 | 93 | 2 | C0014550 | |
| Disease | Epilepsy, Myoclonic, Infantile | 4.35e-04 | 10 | 93 | 2 | C0917800 | |
| Disease | Congenital myasthenic syndrome | 4.35e-04 | 10 | 93 | 2 | cv:C0751882 | |
| Disease | Myoclonic Astatic Epilepsy | 5.31e-04 | 11 | 93 | 2 | C0393702 | |
| Disease | Congenital myopathy (disorder) | 6.35e-04 | 12 | 93 | 2 | C0270960 | |
| Disease | MMR-related febrile seizures | 1.00e-03 | 15 | 93 | 2 | EFO_0006519 | |
| Disease | anemia (implicated_via_orthology) | 1.00e-03 | 15 | 93 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 1.15e-03 | 16 | 93 | 2 | C0751885 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 1.15e-03 | 16 | 93 | 2 | C0393706 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 1.30e-03 | 17 | 93 | 2 | C0751883 | |
| Disease | muscular dystrophy (is_implicated_in) | 1.30e-03 | 17 | 93 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 1.45e-03 | 18 | 93 | 2 | HP_0002373 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 1.62e-03 | 19 | 93 | 2 | C0751884 | |
| Disease | Myasthenic Syndromes, Congenital | 2.59e-03 | 24 | 93 | 2 | C0751882 | |
| Disease | Left Ventricular Hypertrophy | 2.81e-03 | 25 | 93 | 2 | C0149721 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NPKQELRGRGRGILI | 396 | Q86US8 | |
| KLLGDVRLNILVLGG | 166 | Q9UJX5 | |
| AGGFLGQRIIRLLVK | 11 | P14060 | |
| RGLLAGLFQKKLLRG | 526 | P33076 | |
| GRSGAARGLLLQKVR | 371 | O00468 | |
| RAKVQLGGLLLSLLG | 6 | C9JDP6 | |
| LILTGAGALNKVLGR | 1846 | Q13085 | |
| GLRRLFLKDNGLVGI | 411 | P35858 | |
| LATLRGQVLLGRGVG | 336 | P18089 | |
| GLLRKEAGRLQRVGG | 11 | Q63HQ0 | |
| EGLKRGTLIQGVLRI | 61 | Q8IYB7 | |
| LLGLLGRGVGKNEEL | 11 | Q04844 | |
| GHALLRAVGQGKLRL | 6 | Q69YU3 | |
| ILRKARGNLELRPGG | 1866 | Q96SN8 | |
| AAKARLELLGRQLGA | 196 | Q9HCJ3 | |
| EVLRGLGKLILKRSG | 3466 | Q9NU22 | |
| GELGRVQDFLGLKRI | 306 | Q9Y662 | |
| VLKRLRLQKRGTGGV | 311 | P12277 | |
| ALGLRNRGKGVRAVL | 16 | Q96L50 | |
| GLLRSLLERGQQLGV | 886 | Q9BY66 | |
| GRIKRGDVLLNINGI | 511 | Q8N448 | |
| RGRVGPLLACLLGKQ | 621 | P22079 | |
| RNKGLRLAQGAVGLL | 1511 | Q5H8C1 | |
| LHQKLAGRGLIKGRD | 356 | Q9ULK4 | |
| VGLGRTLAGKLVEQR | 1046 | O95163 | |
| GELGRVQDFLGLKRI | 321 | Q9Y663 | |
| GLLGLGHLALNRRKV | 421 | A6NGR9 | |
| EIQGFLQLRGSGRKL | 231 | Q14451 | |
| RGLRTLLAKNNRLGG | 91 | Q96CX6 | |
| GQAAGLGLVGKRLSL | 251 | Q15722 | |
| LGGLLGRQRLLLRMG | 111 | Q9BZ23 | |
| ILNRKGGGNLLGIIV | 171 | Q3SYC2 | |
| LGRGLSGAKVLLLAG | 216 | Q6P988 | |
| HKLRLGFQRLLGLGQ | 301 | Q8NH76 | |
| RKNFLRVGHLVLIGG | 211 | Q9UMR5 | |
| LVLIGAQGVGRRSLK | 341 | Q9NZW5 | |
| GRAKELLGQGLLLRS | 641 | B5ME19 | |
| KQIFISGGRLLIRLG | 3141 | Q9C0G6 | |
| RLIGRLGQLGLKEGF | 2171 | Q9Y2F5 | |
| LLIQKALVRGGLGTL | 1786 | Q13698 | |
| SLGLGLGLGLRKLEK | 36 | O14638 | |
| GLLEARGILGLKRNK | 511 | Q99741 | |
| DGLLRGLGKLRQVSL | 356 | P40197 | |
| ELQGLRGVLQGLSGR | 191 | Q9Y6C2 | |
| LEKLVGGQAGLGRRL | 776 | Q9Y6C2 | |
| GVLGGKLRQRLGLQL | 46 | O95865 | |
| AGGAKILGVLRVLRL | 1386 | O95180 | |
| RVNKGGILIRSARGI | 581 | P54803 | |
| LLALGLRGLQAGARR | 11 | Q9UHL4 | |
| VGVLLRKLEAGIRGI | 491 | Q08211 | |
| IALSIKLLRLGGIGQ | 801 | Q08211 | |
| AGALRGLGQLKELEI | 221 | Q6UY18 | |
| LRQLVKDRLGGRSGG | 131 | Q15084 | |
| GKRALELALLQGLLG | 1266 | Q9P2P1 | |
| GRTLGLLVKRLEKGG | 296 | Q8TEW0 | |
| IGVRLNSLLGRKGSL | 426 | Q6ZN16 | |
| VIRGLAGALKLDLGL | 916 | O14607 | |
| QRTGRLFGGLILDIK | 576 | Q9Y6M7 | |
| NLQIAIGRIKLGIGF | 821 | P35499 | |
| GLSQVLLRGGGQVLL | 631 | Q9UKY4 | |
| IGDIINLGLKGREGR | 726 | O15061 | |
| ILTRLRLQKRGTGGV | 311 | P06732 | |
| RLLLQAGKAGLQGKR | 71 | Q6IN84 | |
| ALRGKLEGLLSRGIR | 171 | O14841 | |
| PGARGLNLLIRKNGR | 1211 | O14841 | |
| RIGRILRLVKGAKGI | 1616 | Q15858 | |
| GLLKLRGLLGFVGTL | 51 | Q03519 | |
| ARIGRILRLIKGAKG | 1626 | Q9NY46 | |
| QRTGRLFGGLVLDIK | 446 | Q2Y0W8 | |
| GLRGRKGNLAICVII | 56 | Q16585 | |
| AARGLGQLGEAVKRL | 1531 | A1L4H1 | |
| LCGGKGLDQLIQRLL | 411 | O75570 | |
| RGKTGLRLRKVDQGL | 116 | Q9H190 | |
| ARIGRILRLIKGAKG | 1641 | P35498 | |
| LLGEAGKQLRRRAGL | 501 | P49748 | |
| QLIKRRGKLGLVGVN | 61 | P53396 | |
| RGKLGLVGVNLTLDG | 66 | P53396 | |
| RRKLGEDGIFLVLLG | 111 | P35523 | |
| LRQGRLLGCLKGLAG | 256 | Q6RFH5 | |
| GNLAVLLTLGQLGRK | 51 | P47901 | |
| KLLRGGLAERLNGLQ | 256 | Q14159 | |
| RHKLIKGVERLLGGQ | 1076 | O95271 | |
| VRGGVAGQLRLLGTL | 421 | A8MQ27 | |
| ARIGRILRLIKGAKG | 1631 | Q99250 | |
| RDGSKIRNLLGLALG | 31 | Q8N5L8 | |
| IRNLLGLALGRLEGG | 36 | Q8N5L8 | |
| LGRRLGISRLQGLGE | 166 | Q9P1Z0 | |
| HKILQGELGGRRALL | 701 | Q9H254 | |
| LLFKQGRAGLIRGVV | 321 | Q9HCJ6 | |
| GRAGLIRGVVEKLIG | 326 | Q9HCJ6 | |
| RGLGVEIAKNIILGG | 81 | P22314 | |
| RLGAGNKIGGRRLIV | 31 | Q92979 | |
| NKIGGRRLIVVLEGA | 36 | Q92979 | |
| GLLGILVCNLLKRKG | 176 | Q969Z4 | |
| VGVLAKGLLLRGDRN | 791 | Q96KR1 | |
| KRRKGLVPGLVNLGN | 61 | Q70CQ3 | |
| KTLGILGLGRIGREV | 146 | O43175 | |
| VALKLGLLLRGDQLG | 66 | Q8WVP5 | |
| GQLGVGLANLLRKRF | 61 | Q8IZJ6 | |
| IRRGLDRILKNAGVG | 481 | Q8N8K9 |